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ABSTRACT
Introduction – Concerns have been raised about the quality of inpatient care received by patients with a diag-
nosis of personality disorder.
Objectives – The aim of this study was to examine the quality of care received by inpatients with an anxiety or
depressive disorder, comparing subgroups with or without a co-morbid personality disorder.
Method –We used a retrospective case-note review of 3 795 patients admitted to inpatient psychiatric wards in
England, utilizing data from the National Clinical Audit of Anxiety and Depression. Data were gathered on all
acute admissions with an anxiety or depressive disorder over a 6-month period, for a number of measures
reflecting quality of care derived from national standards. Association of coexisting personality disorder with
quality of care was investigated using multivariable regression analyses.
Results – Four hundred sixteen (11.0%) of the patients had a co-co-morbid diagnosis of personality disorder.
Patients with personality disorder were less likely to have been asked about prior responses to treatment in their
initial assessment (odds ratio (OR) = 0.67, 95% confidence interval (CI) 0.50 to 0.89, p = 0.007). They
were less likely to receive adequate notice in advance of their discharge (OR = 0.87, 95% CI 0.65 to 0.98,
p = 0.046). They were more likely to be prescribed medication at the point of discharge (OR = 1.52, 95%
CI 1.02 to 2.09, p = 0.012) and less likely to have been provided with information about the medicines they
were taking (OR = 0.86, 95% CI 0.69 to 0.94, p = 0.048). In addition, the carers of patients with
co-morbid personality disorder were less likely to have been provided with information about available support
services (OR = 0.73, 95% CI 0.51 to 0.93, p = 0.045).
Conclusion –We found evidence of poorer quality of care for patients with co-morbid personality disorder who
were admitted to psychiatric hospital for treatment of anxiety or depressive disorders, highlighting the need for im-
proved clinical care in this patient group. © 2020 John Wiley & Sons, Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction
in any medium, provided the original work is properly cited.
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Introduction
Anxiety disorders and unipolar depression are
common conditions, ranking first and second re-
spectively out of all mental disorders in lifetime
prevalence.1 Personality disorders frequently coex-
ist (i.e. are ‘co-morbid’) with these conditions1,2
and have been associated with increased func-
tional impairment and worse treatment
outcomes,3–9 with increased cost to healthcare
systems.10 For example, a meta-analysis of treat-
ment for depression showed that patients with
co-morbid personality disorder had a twofold risk
of inadequate response to antidepressant
treatment.11
The reasons for a lower chance of optimal out-
comes are unclear. While ‘patient factors’ such as
adherence to treatment are important,12 there
may also be factors relating to quality of care that
patients receive. Poor therapeutic alliance and
staff attitudes are likely to be implicated—the per-
vasive stigma associated with diagnoses of person-
ality disorder has been well characterized, and
unfortunately, psychiatric services are not exempt
from this.13 Patients with the diagnosis of person-
ality disorder are often viewed as ‘less unwell’ and
‘more in control’ of their behaviour than individ-
uals with other diagnoses,14 and there can be
strongly held views that their admission to inpa-
tient settings is unjustified compared with that of
individuals with other diagnoses.15
The use of pharmacological treatments in pa-
tients with personality disorder is controversial,16
and current National Institute for Health and
Care Excellence (NICE) guidance advises against
using medications directly to treat borderline per-
sonality disorder or its symptoms, except for
short-term treatment during a crisis.17 Concerns
have also been raised about the potential overuse
of medication and poor monitoring for side effects
when psychotropic drugs are prescribed to these
patients.18 However, research into clinical prac-
tice has repeatedly found that patients with per-
sonality disorder are routinely prescribed more
psychotropic medication than those without such
a diagnosis, irrespective of co-morbid mental
disorders.19
Inpatients with personality disorder have
higher levels of unmet need than those with other
conditions,20 and front-line clinicians have re-
ported concerns about the quality of inpatient care
for patients with the diagnosis of borderline per-
sonality disorder.13,15,21–23 Most studies of the
general quality of inpatient care for patients with
personality disorder have been qualitative24 and
have lacked validated outcome measures, focusing
instead on exploring service users’ subjective expe-
riences of care.25–27
To date, there have been no other studies spe-
cifically examining inpatient care for anxiety and
depression, for patients with co-morbid personality
disorder. We therefore aimed to investigate
whether the presence of a co-morbid personality
disorder affects the quality of care received by in-
patients with a primary diagnosis of an anxiety or
depressive disorder. We conducted a secondary
analysis of data from a national audit of inpatient
care for people with anxiety and depression and
examined the impact of co-morbid personality dis-
order on a broad range of care quality indicators.
Methods
Setting and participants
Data were collected as part of the National Clini-
cal Audit of Anxiety and Depression in England.
A detailed account of the methods used in the au-
dit is available elsewhere.28 All National Health
Service (NHS)-funded inpatient mental health
services in England that provide care to adult pa-
tients with diagnoses of anxiety and/or depressive
disorders were invited to take part.
All participating organizations were asked to
provide an anonymized list of eligible patients ad-
mitted to hospital between 1 April and 30 Sep-
tember 2017. Where patients had more than one
admission during this sampling window, only the
first admission was used. Patients were eligible for
inclusion in the audit if they were aged 16 years
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or above and had a primary diagnosis of an anxiety
or depressive disorder at the point of discharge
(ICD-10 coding). Patients were excluded if they
had a primary diagnosis of any psychotic disorder
(including F32.3 severe depressive episode with
psychotic symptoms), bipolar affective disorder,
cyclothymia or mania or if they were admitted to
a forensic service or long-stay ward such as a reha-
bilitation service.
Data collection
A total of 54 organizations providingmental health
services took part in the audit. Staff from each orga-
nization were asked to complete an online ‘audit of
practice’ tool for each of their sampled patients,
using data from clinical records only. Five of each
organization’s sampled patients were audited twice
by two separate auditors, and the results were com-
pared by the audit team to determine interrater re-
liability. Three organizations were also selected at
random for quality assurance visits by an external
clinician and member of the audit team to examine
whether the submitted data were accurate.
The data collection tool was based on NICE
guidance for inpatient services29–31 and the ‘Stan-
dards for Inpatient Mental Health Services’ as de-
fined by the Royal College of Psychiatrists’
College Centre for Quality Improvement32 and
was developed in collaboration with users and pro-
viders of psychiatric inpatient services, as well as
representatives with lived experience of
supporting patients. It included questions on pa-
tient demographics, details of admission (time/
date of admission/discharge), diagnosis, assess-
ment, care planning, medication, psychological
therapies, physical health, discharge, readmission,
crisis planning and follow-up. The tool was piloted
by six volunteer trusts prior to the main audit, to
ensure the process was understandable and feasible
with the guidance documents provided.
The National Research Ethics Service and the
Ethics and Confidentiality Committee of the Na-
tional Information Governance Board advised
that formal ethical approval was not required
because this was an audit and patient identifiable
data were not being collected. All procedures con-
tributing to this work comply with the ethical
standards of the relevant national and institu-
tional committees on human experimentation
and with the Declaration of Helsinki of 1975, as
revised in 2008.
Exposure, outcome measures and covariates
Patients were categorized according to whether
they had a confirmed secondary diagnosis of ‘per-
sonality disorder’ (ICD code F60), as recorded on
the audit tool. No information on specific person-
ality disorder subtype was gathered. Quality of
clinical care was assessed using data from 24 ques-
tions (see Table 1) based on the ‘Standards for In-
patient Mental Health Services’ as defined by the
Royal College of Psychiatrists’ College Centre for
Quality Improvement.32
A number of categorical variables were also re-
corded as covariates—primary and secondary diag-
noses, age, gender, ethnicity, employment status,
accommodation status, length of admission and
mode of admission (whether admitted under the
provisions of the Mental Health Act).
Information was also recorded on which medi-
cations patients were prescribed, and these were
categorized by class, i.e. antidepressant, anxiolytic
(including benzodiazepine or other), antipsychotic
and mood stabilizer.
A full copy of the national audit report is avail-
able online.33
Statistical methods
All study analyses were conducted using SPSS.34
We first calculated the proportion of patients who
had a secondary diagnosis of personality disorder.
The association of covariates (primary/secondary
diagnosis, age, gender, ethnicity, employment/
accommodation status and mode of admission)
with personality disorder was investigated using
univariate logistic regression. The association of
personality disorder with each of the primary
Co-morbid PD inpatient anxiety depression
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outcome measures was then measured using bino-
mial logistic regression.
As patients were clustered within different ser-
vices and because quality of care for patients within
a given service may be more similar than for pa-
tients in different services, all analyses were ad-
justed using multilevel logistic regression.
Initially, the association between personality disor-
der and each quality of care variable was examined
without considering any confounding variables.
The analysis was then repeated, adjusting for
covariates found to be associated with the primary
outcome measures (including source organization).
Results
Fifty-four NHS trusts submitted data for the audit
(all of those which were eligible). Data from 3 795
patients’ case notes were analysed, of which 416
(11.0%) had a secondary diagnosis of personality
disorder.
Table 1: ‘Quality of Clinical Care’ measures (primary outcome measures)
1 Did the (initial) assessment include details about the service user’s past response to treatment?
2 Did the (initial) assessment consider whether the service user had a history of trauma?
3 Was there a documented current BMI?
4 Was there a documented current smoking status?
5 Was the identified family member, friend or carer provided with information about available
support services and/or a support plan? (where an appropriate family member, friend or
carer had been identified)
6 Was the identified family member, friend or carer offered a carer’s assessment? (where an
appropriate family member, friend or carer had been identified)
7 Did the service user have a care plan?
8 Is there evidence that the care plan was jointly developed between the service user and
clinician?
9 Was the service user given a copy of their care plan?
10 Was the service user referred for psychological therapy?
11 Did the service user commence psychological therapy before the end of the audit period?
(only among those who had been referred)
12 Was the service user given at least 24-h notice of discharge?
13 Was the identified family member, friend or carer given at least 24-h notice of discharge?
(where an appropriate family member, friend or carer had been identified)
14 Was the service user being prescribed psychotropic medication at the point of discharge?
15 Was the service user given verbal and/or written information about their medication prior to
discharge?
16 Did a review of the service user’s medication(s) take place prior to discharge?
17 At discharge, was the service user given ‘to take home’ (TTO) medication
18 Did the service user have a crisis plan at the point of discharge?
19 Was a discharge letter sent to the service user’s GP within 24 h?
20 Was a care plan sent to a nominated person in an accepting service? (where an appropriate
service had been identified)
21 Did the service user receive follow-up within 48 h of discharge?
22 Did a review of the service user’s medication(s) take place between discharge and the end
of the audit period?
23 Was an appropriately validated outcome measure completed?
24 Was the service user readmitted to hospital between discharge and the end of the audit period?
BMI, body mass index; GP, general practitioner.
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Table 2 summarizes the demographic and clin-
ical characteristics of patients with co-morbid per-
sonality disorder compared with those without
such co-morbidity. Recorded co-morbid personal-
ity disorder was more likely in patients aged less
than 34 years but less likely among patients aged
between 55 and 64 years. Female patients and pa-
tients who were recorded as having long-term
sickness were more likely to have a diagnosis of
co-morbid personality disorder, but Asian patients
and patients who were employed or retired were
less likely to have a co-morbid diagnosis. The pres-
ence of personality disorder was not associated
with differences in the mode of admission
(whether admitted compulsorily under the UK
Mental Health Act), wait time for beds or length
of admission.
Table 3 and Figure 1 summarize the findings of
multivariate regression analyses of the association
of personality disorder with primary outcome mea-
sures. Patients with personality disorder were less
likely to have been asked about prior responses
to treatment in their initial assessment (odds ratio
(OR) = 0.67, 95% confidence interval (CI) 0.50
to 0.89, p = 0.007) and less likely to have had a re-
corded body mass index (BMI) (OR = 0.72, 95%
CI 0.56 to 0.92, p = 0.008). In addition, the carers
of patients with co-morbid personality disorder
were less likely to have been provided with infor-
mation about available support services
(OR = 0.73, 95% CI 0.51 to 0.93, p = 0.045).
Patients with co-morbid personality disorder
were less likely to receive adequate (24 h) notice
in advance of their discharge (OR = 0.87, 95%
CI 0.65 to 0.98, p = 0.046). Although they were
more likely to have been prescribed medication
at the point of discharge (OR = 1.52, 95% CI
1.02 to 2.09, p = 0.012), they were less likely to
have been provided with information about the
medicines they were taking (OR = 0.86, 95% CI
0.69 to 0.94, p = 0.048). Table 4 summarizes the
multivariate regression analyses of the association
of personality disorder with prescription of psycho-
tropic medications. Patients with co-morbid per-
sonality disorder were more likely to be
Pe
rs
on
al
it
y
di
so
rd
er
N
o
pe
rs
on
al
it
y
di
so
rd
er
U
na
dj
us
te
d
p
A
dj
us
te
d†
p
M
ea
n
M
ed
ia
n
ST
D
M
ea
n
M
ed
ia
n
ST
D
B
co
ef
fi
ci
en
t
95
%
C
I
B
co
ef
fi
ci
en
t
95
%
C
I
W
ai
t
ti
m
e
fo
r
be
d
n
=
2
20
7
38
.6
3
h
5.
27
h
69
.7
1
h
31
.7
0
h
5.
41
h
57
.0
6
h
6.
93
h
1
4.
67
to
28
.5
4
h
0.
52
9
8.
70
h

10
.6
6
to
28
.0
7
h
0.
37
8
Le
ng
th
of
ad
m
is
si
on
n
=
3
79
5
25
.7
6
da
ys
11
.0
0 da
ys
44
.9
1
da
ys
26
.3
6 da
ys
13
.0
0 da
ys
39
.0
3 da
ys

0.
60
da
ys

5.
06
to
3.
84
da
ys
0.
78
8
2.
76
da
ys

2.
15
to
7.
66
da
ys
0.
27
1
C
I,
co
nfi
de
nc
e
in
te
rv
al
;O
R
,o
dd
s
ra
ti
o.
a A
dj
us
te
d
fo
r
N
at
io
na
lH
ea
lt
h
Se
rv
ic
e
tr
us
t,
ag
e,
ge
nd
er
,e
th
ni
ci
ty
,e
m
pl
oy
m
en
t
st
at
us
an
d
pr
im
ar
y/
se
co
nd
ar
y
di
ag
no
si
s.
Ryan Williams et al.
© 2020 The Authors Personality and Mental Health Published by John Wiley & Sons Ltd (2020)
DOI: 10.1002/pmh
T
ab
le
3:
A
ss
oc
ia
ti
on
of
pe
rs
on
al
it
y
di
so
rd
er
w
it
h
qu
al
it
y
of
ca
re
m
ea
su
re
s
Pr
im
ar
y
ou
tc
om
e
Pe
rs
on
al
it
y
di
so
rd
er
N
/t
ot
al
(%
)
N
o
pe
rs
on
al
it
y
di
so
rd
er
N
/t
ot
al
(%
)
O
R
95
%
C
I
p
A
dj
us
te
da
O
R
95
%
C
I
p
A
ss
es
sm
en
t
in
cl
ud
ed
tr
au
m
a?
25
8/
32
1
(8
0.
4)
1
98
1/
2
51
5
(7
8.
8)
1.
10
(0
.8
3
to
1.
48
)
0.
50
6
1.
19
(0
.8
6
to
1.
65
)
0.
29
8
A
ss
es
sm
en
t
in
cl
ud
ed
pa
st
tr
ea
tm
en
t?
24
1/
32
3
(7
4.
6)
2
01
1/
2
43
5
(8
2.
6)
0.
62
(0
.4
7
to
0.
81
)
0.
00
1
0.
67
(0
.5
0
to
0.
89
)
0.
00
7
B
M
I
re
co
rd
ed
23
1/
34
3
(6
7.
3)
2
07
8/
2
86
0
(7
2.
7)
0.
78
(0
.6
1
to
0.
98
)
0.
03
8
0.
72
(0
.5
6
to
0.
92
)
0.
00
8
Sm
ok
in
g
st
at
us
re
co
rd
ed
27
1/
34
3
(7
9.
0)
2
40
3/
2
86
0
(8
4.
0)
0.
72
(0
.5
4
to
0.
95
)
0.
01
8
0.
75
(0
.5
6
to
1.
01
)
0.
05
9
C
ar
e
pl
an
co
m
pl
et
ed
30
8/
34
3
(8
9.
8)
2
60
7/
2
85
9
(9
1.
2)
0.
85
(0
.5
9
to
1.
24
)
0.
39
5
0.
84
(0
.5
7
to
1.
24
)
0.
38
8
C
ar
e
pl
an
de
ve
lo
pe
d
jo
in
tl
y
25
5/
30
8
(8
2.
8)
2
13
0/
2
60
7
(8
1.
7)
1.
08
(0
.7
9
to
1.
47
)
0.
63
9
1.
28
(0
.9
1
to
1.
79
)
0.
15
6
Pa
ti
en
t
re
ce
iv
ed
co
py
of
ca
re
pl
an
16
3/
30
8
(5
2.
9)
1
48
2/
2
60
7
(5
6.
8)
0.
85
(0
.6
7
to
1.
08
)
0.
18
9
0.
93
(0
.7
3
to
1.
18
)
0.
52
9
C
ar
er
pr
ov
id
ed
in
fo
re
:s
up
po
rt
se
rv
ic
es
av
ai
la
bl
e
98
/1
74
(5
6.
3)
1
12
4/
1
78
5
(6
3.
0)
0.
76
(0
.5
5
to
1.
04
)
0.
08
4
0.
73
(0
.5
1
to
0.
93
)
0.
04
5
C
ar
er
of
fe
re
d
ca
re
ne
ed
s
as
se
ss
m
en
t
43
/1
74
(2
4.
7)
44
4/
1
78
5
(2
4.
9)
0.
99
(0
.6
9
to
1.
42
)
0.
96
3
1.
05
(0
.7
4
to
1.
52
)
0.
75
9
C
ri
si
s
pl
an
in
pl
ac
e
at
di
sc
ha
rg
e
24
6/
34
3
(7
1.
7)
2
13
6/
2
85
9
(7
4.
7)
0.
86
(0
.6
7
to
1.
10
)
0.
23
0
0.
84
(0
.6
3
to
1.
10
)
0.
20
5
Pr
es
cr
ib
ed
m
ed
ic
at
io
n
at
di
sc
ha
rg
e?
31
1/
34
3
(9
0.
7)
2
49
8/
2
86
0
(8
7.
3)
1.
41
(0
.9
6
to
2.
06
)
0.
07
6
1.
52
(1
.0
2
to
2.
09
)
0.
01
2
M
ed
ic
at
io
n
re
vi
ew
ed
du
ri
ng
ad
m
is
si
on
?
27
3/
31
0
(8
8.
1)
2
16
2/
2
49
3
(8
6.
7)
1.
13
(0
.7
9
to
1.
62
)
0.
50
9
1.
43
(0
.9
6
to
2.
06
)
0.
07
9
Pa
ti
en
t
gi
ve
n
in
fo
re
:m
ed
ic
at
io
n?
20
9/
31
1
(6
7.
1)
1
83
6/
2
49
8
(7
3.
5)
0.
85
(0
.6
6
to
1.
05
)
0.
16
0
0.
86
(0
.7
2
to
0.
98
)
0.
04
8
T
T
A
m
ed
ic
at
io
n
pr
ov
id
ed
at
di
sc
ha
rg
e?
26
7/
31
4
(8
5.
0)
2
28
0/
2
69
7
(8
4.
5)
1.
04
(0
.7
5
to
1.
44
)
0.
81
9
1.
22
(0
.8
3
to
1.
77
)
0.
31
0
M
ed
ic
at
io
n
re
vi
ew
ed
af
te
r
di
sc
ha
rg
e?
18
5/
22
2
(8
3.
3)
1
50
3/
1
72
9
(8
6.
9)
0.
75
(0
.5
1
to
1.
10
)
0.
14
0
0.
88
(0
.6
2
to
1.
46
)
0.
95
1
R
ef
er
re
d
to
ps
yc
ho
lo
gy
?
17
5/
41
6
(4
2.
1)
1
20
8/
3
37
8
(3
5.
8)
1.
21
(0
.9
6
to
1.
46
)
0.
07
8
1.
26
(1
.0
2
to
1.
48
)
0.
04
2
C
om
m
en
ce
d
ps
yc
ho
lo
gy
?
91
/1
48
(6
1.
5)
68
1/
1
05
3
(6
4.
7)
0.
87
(0
.6
1
to
1.
24
)
0.
44
9
0.
91
(0
.6
1
to
1.
36
)
0.
65
3
O
ut
co
m
e
m
ea
su
re
co
m
pl
et
ed
25
2/
41
6
(6
0.
6)
2
06
2/
3
37
9
(6
1.
0)
0.
98
(0
.8
0
to
1.
21
)
0.
86
0
1.
09
(0
.8
6
to
1.
39
)
0.
48
0
R
ea
dm
is
si
on
w
it
hi
n
au
di
t
pe
ri
od
68
/3
58
(1
9.
0)
34
4/
2
94
3
(1
1.
7)
1.
77
(1
.3
3
to
2.
36
)
<
0.
00
1
1.
82
(1
.3
1
to
2.
34
)
<
0.
00
1
Pa
ti
en
t
gi
ve
n
no
ti
ce
of
di
sc
ha
rg
e
24
7/
35
8
(6
9.
9)
2
28
2/
2
94
3
(7
7.
5)
0.
91
(0
.7
3
to
1.
05
)
0.
10
6
0.
87
(0
.6
5
to
0.
98
)
0.
04
6
C
ar
er
gi
ve
n
no
ti
ce
of
di
sc
ha
rg
e
12
5/
18
0
(6
9.
4)
1
27
6/
1
83
1
(6
9.
7)
0.
99
(0
.7
1
to
1.
38
)
0.
94
6
1.
01
(0
.7
8
to
1.
37
)
0.
18
3
D
is
ch
ar
ge
le
tt
er
se
nt
to
G
P
w
it
hi
n
48
h
15
8/
30
0
(5
2.
7)
1
32
5/
2
53
3
(5
2.
3)
1.
01
(0
.8
0
to
1.
29
)
0.
90
7
1.
06
(0
.8
0
to
1.
38
)
0.
69
5
C
op
y
of
ca
re
pl
an
se
nt
to
ac
ce
pt
in
g
se
rv
ic
e
13
8/
21
1
(6
5.
4)
1
38
8/
1
81
9
(7
6.
3)
0.
59
(0
.4
3
to
0.
79
)
0.
00
1
0.
68
(0
.4
7
to
0.
98
)
0.
04
2
Fo
llo
w
-u
p
w
it
hi
n
48
h
of
di
sc
ha
rg
e
17
1/
29
8
(5
7.
4)
1
38
1/
2
52
8
(5
4.
6)
1.
12
(0
.8
8
to
1.
43
)
0.
36
6
1.
12
(0
.8
5
to
1.
48
)
0.
41
8
C
I,
co
nfi
de
nc
e
in
te
rv
al
;O
R
,o
dd
s
ra
ti
o;
G
P,
ge
ne
ra
lp
ra
ct
it
io
ne
r.
a A
dj
us
te
d
fo
r
N
at
io
na
lH
ea
lt
h
Se
rv
ic
e
tr
us
t,
ag
e,
ge
nd
er
,e
th
ni
ci
ty
,e
m
pl
oy
m
en
t
st
at
us
an
d
pr
im
ar
y/
se
co
nd
ar
y
di
ag
no
si
s.
Co-morbid PD inpatient anxiety depression
© 2020 The Authors Personality and Mental Health Published by John Wiley & Sons Ltd (2020)
DOI: 10.1002/pmh
prescribed anxiolytics (OR = 1.52, 95% CI 1.18 to
1.96, p = 0.001), antipsychotics (OR = 1.93, 95%
CI 1.52 to 2.45, p < 0.001) and mood stabilizers
(OR = 2.25, 95% CI 1.48 to 3.43, p < 0.001).
Following discharge, it was less likely that a
copy of their care plan was forwarded on to an
accepting community service (OR = 0.68, 95%
CI 0.47 to 0.93, p = 0.042), and they were
Figure 1: Forest plot of association of coexisting personality disorder with quality of care measures. BMI, body mass index; PD,
personality disorder
Table 4: Association of personality disorder with medication prescribed
Medication
Personality disorder
N/total (%)
No personality disorder
N/total (%) OR 95% CI p
Adjusteda OR
95% CI p
Antidepressant 317/416 (76.2) 2 647/3 379 (78.3) 0.89 (0.70 to 1.13) 0.320 1.07 (0.81 to 1.42) 0.634
Anxiolytic 146/416 (35.1) 953/3 379 (28.3) 1.38 (1.11 to 1.71) 0.003 1.52 (1.18 to 1.96) 0.001
Benzodiazepine 61/416 (14.7) 438/3 379 (13.0) 1.15 (0.86 to 1.54) 0.333 1.37 (0.97 to 1.92) 0.072
Antipsychotic 197/416 (47.4) 1 064/3 379 (31.5) 1.96 (1.59 to 2.40) <0.001 1.93 (1.52 to 2.45) <0.001
Mood stabilizer 43/416 (10.3) 199/3 379 (5.9) 1.84 (1.30 to 2.61) <0.001 2.25 (1.48 to 3.43) <0.001
aAdjusted for National Health Service trust, age, gender, ethnicity, employment status and primary/secondary diagnosis.
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significantly more likely to be readmitted during
the audit period (OR = 1.82, 95% CI 1.31 to
2.54, p < 0.001). Patients with personality disor-
der were more likely to be referred for psychologi-
cal therapy (OR = 1.26, 95% CI 1.05 to 1.48,
p = 0.042) but were no more likely to have com-
menced such therapy at the end of the audit
period.
Discussion
The findings from this study suggest that the qual-
ity of inpatient care for anxiety and depression
provided is poorer when people have
co-occurring personality disorder. We found dif-
ferences across multiple stages of inpatient admis-
sion (including the initial assessment process,
treatments offered and discharge planning). Al-
though there were significant demographic differ-
ences between groups, the differences in care
standards were independent of demographic
factors.
In most areas where there were differences be-
tween groups, patients with co-occurring personal-
ity disorder received lower quality care than those
without. However, patients with personality disor-
der were more likely to be referred for psychologi-
cal therapy and more likely to be prescribed
psychotropic medication. Patients with personal-
ity disorder were more likely to be prescribed psy-
chotropic medications (other than
antidepressants) but were significantly less likely
to be given information about the medication
they were prescribed.
Strengths and limitations
Data were obtained from a large heterogeneous
sample, derived from every NHS trust providing
acute psychiatric inpatient care for patients with
anxiety and depression in England. We expect
that our findings would be generalizable to similar
patient groups in wider inpatient clinical practice.
The primary outcome measures we used to assess
quality of clinical care were based on NICE
guidance29–31 and standards for inpatient services
published by the Royal College of Psychiatrists32
and were refined with feedback from an expert
group of service users and providers.
There are important limitations. Data were
gathered from a retrospective case note audit and
are therefore dependant on accurate reporting and
documentation of events at the time of occurrence.
Case notes were written by clinicians and may not
fully capture patient/carer perspectives or experi-
ence (e.g. whether they were given sufficient infor-
mation about medication or available services).
Restricting the sample to patients with a pri-
mary diagnosis of an anxiety disorder or depressive
illness means that the results may not be generaliz-
able to other patient groups such as those with
other primary diagnoses or those who were admit-
ted to hospital because of behaviour or symptoms
related to their personality disorder alone.
The prevalence of co-morbid personality disor-
der in our sample (11.0%) also fell short of esti-
mates obtained from previous studies of
inpatients with anxiety and depression.35,36 There
is evidence that personality disorders are
underdiagnosed in clinical samples37 and patients
with emotionally unstable, histrionic and dissocial
personality traits may be over-represented among
those who do receive a formal diagnosis.35 Our
study did not differentiate between subtypes of
personality disorder, so we were unable to identify
whether this was the case in our sample. There
may, therefore, be patients who fulfil diagnostic
criteria for personality disorder but are less likely
to receive a formal diagnosis (e.g. potentially those
with avoidant/dependant/anankastic traits) to
whom our conclusions do not apply.
Although we gathered detailed clinical infor-
mation about patients (primary/secondary diagno-
sis, mode/length of admission, etc.), there may
have been important but ‘uncaptured’ differences
between groups, such as variations in illness sever-
ity within one primary diagnosis, or level of sup-
port in the community. Finally, as the data are
cross-sectional, we are unable to fully explore tem-
poral associations between diagnosis of personality
Co-morbid PD inpatient anxiety depression
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disorder and measures of quality of care. The pres-
ence of co-morbid personality disorder (and asso-
ciated behaviours or symptoms) may have led to
variation in the quality of clinical care, bur poor
quality of care might have resulted in frustration
and behaviours or symptoms that made a diagnosis
of personality disorder more likely.
Implications
We found evidence that quality of care in patients
with anxiety or depression who were admitted to
psychiatric inpatient services varies between those
with or without a co-morbid personality disorder,
the majority of differences suggesting shortfalls in
care for patients with co-morbidity. This is consis-
tent with previous findings that patients with per-
sonality disorder generally describe inpatient
treatment as a negative experience.25–27 Those
studies focused primarily on hospitalization for
behaviour/symptoms associated specifically with
personality disorder (primarily emotionally unsta-
ble), and whether hospitalization is effective for
these indications remains controversial,38,39 al-
though there is some evidence of its utility.40
Our study had a different focus, but its findings in-
dicate that even when admission is indicated for
the treatment of an anxiety or depressive disorder,
care may be affected by the presence of co-morbid
personality disorder.
Our study identifies several specific areas where
inpatient care for patients with co-morbid person-
ality disorder could be improved. The first of these
is the initial assessment process, where patients
were less likely to be asked about past responses
to treatment and less likely to have a recorded
BMI (suggesting a less thorough assessment of
physical health needs)—while their carers were
less likely to be given information about support
services available.
Another area of difficulty relates to collabora-
tive decision making with patients with personal-
ity disorder, who were less likely to receive
adequate (24 h) notice in advance of their dis-
charge and less likely to have been provided with
information about the treatment they were given.
In previous studies, 80% of staff surveyed report
finding individuals with a personality disorder di-
agnosis ‘difficult to care for’,21 reporting that they
provoked anger and hostility and describing them
as ‘manipulative’ or ‘threatening’,22,23 suggesting
that staff may not feel confident in collaborative
working with this patient group.
The fact that discharge planning is affected is a
particular area of concern, as previous studies have
identified this process of ‘ending’ as a crucial stage
when considering the efficacy of inpatient treat-
ment. Joint discharge planning has been shown
to decrease feelings of anxiety/rejection often ex-
perienced by patients with personality disorder
prior to discharge,41 while clear links have been
established between unplanned discharge and feel-
ings of abandonment (and subsequent suicide
threats) in patients specifically with emotionally
unstable personality disorder.42
There is substantial evidence for the benefits of
involving patients with personality disorder in de-
cisions relating to their treatment. Reductions in
general symptom distress and improvements in in-
terpersonal functioning have been found when pa-
tients with emotionally unstable personality
disorder are given more information about their
diagnosis and treatments available.43 Increasingly,
guidance has emphasized the need for transparent
and collaborative approaches with this population
regarding their diagnosis and care, highlighting
the importance of health literacy and
self-management strategies.13,17,44
Training and support for clinicians and health
service providers may improve care for this popu-
lation and help reduce discrimination within sys-
tems of care. This may include a greater focus on
reflection on the personal impact of working with
patients with personality disorders and could be
incorporated into regular supervision. A particular
emphasis on patients’ likely trauma history, trust
and interpersonal issues may be beneficial.
Existing guidance in this area emphasizes the im-
portance of considering all aspects of the
biopsychosocial formulation and establishing links
Ryan Williams et al.
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between historical trauma and current symptoms
in order to increase compassion, as well as improve
care planning and risk management.45
Patients with personality disorder were more
likely to be readmitted to hospital following dis-
charge. This replicates similar findings from sev-
eral studies46,47 and may be related to the
aforementioned variation in the discharge process
or shortfalls in communication between inpatient
and community services, which were also identi-
fied in this study.
Some of the differences in care identified in our
study are more difficult to interpret—such as the
findings that patients with personality disorder
were more likely to be prescribed psychotropic
medications from a variety of classes and more
likely to be referred for psychological therapy.
These may represent ‘overtreatment’ of primary di-
agnoses in the context of co-morbid personality
disorder or suggest that treatments were being used
to directly target symptoms associated with per-
sonality disorder rather than the primary diagno-
sis. The increased likelihood of referral for
psychological therapy seems more promising.
However, it is worth noting that the increased
likelihood of referral did not equate to an increase
in patients accessing treatment.
More research is needed to explore longer term
outcomes of patients with personality disorder
who receive inpatient treatment for anxiety and
depression. Ideally, this should include assessment
of patient and carer experience as well as measures
such as unplanned readmission and other adverse
events. This may be best achieved through pro-
spective observational studies. These could also
be used to examine the temporal relationship be-
tween quality of care and secondary diagnosis—i.
e. whether poor care may contribute to the expres-
sion of symptoms or difficulties that then lead to a
diagnosis of personality disorder.
While we feel that the variation in care be-
tween patients with personality disorder and those
without is clinically important, it is also worth
noting that the quality of care received by patients
overall (irrespective of co-morbidity) fell below
nationally agreed standards. For example, only
half of patients received a follow-up within 48 h
of discharge, or had a discharge letter sent to their
general practitioner within 24 h, while only a
quarter of carers were offered a care needs assess-
ment. These aspects will be the focus of quality
improvement activities and will be assessed in fu-
ture rounds of the national audit.
Conclusions
This study examined whether the quality of inpa-
tient care patients receive for anxiety and depres-
sion differs if they have a secondary diagnosis of
personality disorder. We found significant differ-
ences in quality of care between those patients
with co-morbid personality disorder and those
without, most differences indicating worse quality
care in patients with personality disorder. This as-
sociation merits further research into factors
obstructing good quality of care for patients with
personality disorder and how these could be
addressed.
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